Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
-
Medical Workers Face Hidden Cancer Risk from Sterilization Gas; New Test from Air by CCSquared Offers Early Detection
-
Eternex Network (eTRNX) Officially Launches Ushering In a New Era of Tokenized Real World Assets
-
Vertex Announces Second Quarter 2025 Financial Results
-
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update
-
Avista Corp. Reports Financial Results for the Second Quarter of 2025, Confirms 2025 Earnings Guidance with Strong Utility Offsetting Investment Losses
-
Gilat Reports Second Quarter 2025 Results
-
ARMOUR Residential REIT, Inc. Announces Pricing of Public Offering of 18,500,000 Shares of Common Stock
-
Nevada Lithium Announces Robust Preliminary Economic Assessment, Reporting US$6.83 Billion After-Tax NPV, 32.3% After-Tax IRR & 2.8 Year Capital Payback for its High-Grade Bonnie Claire Lithium Pr
-
Churchill Discovers High Grade Antimony (9.46% Sb), Together with Gold (35.5 g/t) and Silver (1,118 g/t), 1.2km to the North of Historic Frost Cove Antimony Mine; Metallurgical Studies Underway
-
Sprott Announces Second Quarter 2025 Results
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Innovative Food Holdings, Inc. Announces Second Quarter 2025 Earnings Call
-
Purple Biotech Reports Second Quarter 2025 Financial Results
-
USA Rare Earth to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Capital City Bank Earns 14th Consecutive “Best Companies” Honor, Climbs to 11th Place
-
Bioventus Reports Second Quarter Financial Results
-
Eloro Resources Continues to Expand Higher-Grade Tin and Silver Mineralization in Step-Out Definition Drilling at its Iska Iska Project, Potosí Department, Bolivia
-
Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025
-
Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study
-
Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference
-
EyePoint Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Developments
-
Astec Reports Second Quarter 2025 Results
-
American Shared Hospital Services Announces Second Quarter Financial Results Conference Call
-
Hopewell Fund Announces Anna Brower as Inaugural President
-
Mingteng International’s Subsidiary Entered into Strategic Cooperation Framework Agreement with Suzhou Lvkon Transmission Technology to Strengthen Partnership and Enhance Competitiveness in the New
-
Royalty Pharma Reports Second Quarter 2025 Results
-
Coda Octopus Group Announces that it has recently received an accreditation for ISO:17025 from the United Kingdom Accreditation Services (UKAS) for its ultrasonic calibration services.
-
White Gold Corp. Commences Diamond Drilling on Flagship High Grade White Gold Project
-
Inventus Reports 4.18 gpt Gold and 1.48 Metre Average for Initial Trench 1 North Grade Control Drilling and Provides Update on Bulk Sample Operation
-
OTC Markets Group Welcomes Alkane Resources Limited to OTCQX
-
Trident Resources to Commence Inaugural 5,000m Drill Program at Contact Lake High-Grade Gold Project, Saskatchewan
-
Arvinas Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress
-
BioXcel Therapeutics Announces Publication in Frontiers in Pharmacology on the Effects of Dexmedetomidine (the active ingredient in BXCL-501) on Stress-Mediated Behaviors in Non-clinical Studies
-
Telesat Reports Results for the Quarter and Six Months Ended June 30, 2025
-
Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025
-
Dayforce Reports Second Quarter 2025 Results¹
-
Energous Corporation Announces 1-for-30 Reverse Stock Split
-
Reminder - Stella-Jones Will Hold a Conference Call to Discuss Its Second Quarter Results
-
Entrada Therapeutics Reports Second Quarter 2025 Financial Results
-
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results
-
OMass Therapeutics Appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee
-
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
-
30.1% Gross Margin and Lower Operating Expenses Enable Orion to Generate Positive Adjusted EBITDA on Q1’26 Revenue of $19.6M; Reiterates FY 2026 Outlook
-
YieldMax® ETFs Announces Distributions on ULTY, TSMY, YBIT, LFGY, YMAX, and Others
-
Wabash and Excel Truck Group Expand Trailer Partnership into the Carolinas
-
Finstar: 2025 Charity Month to Launch
